Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study

Currently, there is an increasing interest to apply pre-fusion (pre-F) protein of respiratory syncytial virus (RSV) as antigen for the development of a subunit vaccine. A pre-F-containing powder would increase the flexibility regarding the route of administration. For instance, a pre-F-containing po...

Descripción completa

Detalles Bibliográficos
Autores principales: Beugeling, Max, Amssoms, Katie, Cox, Freek, De Clerck, Ben, Van Gulck, Ellen, Verwoerd, Jeroen A., Kraus, Guenter, Roymans, Dirk, Baert, Lieven, Frijlink, Henderik W., Hinrichs, Wouter L. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835792/
https://www.ncbi.nlm.nih.gov/pubmed/31623333
http://dx.doi.org/10.3390/pharmaceutics11100510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835792/
https://www.ncbi.nlm.nih.gov/pubmed/31623333
http://dx.doi.org/10.3390/pharmaceutics11100510

Ejemplares similares